Next stop, São Paulo! Newland Pharmaceutical is heading to FCE Pharma to connect with partners from Latin America and around the world. We look forward to exploring new opportunities, exchanging ideas, and building long-term partnerships.

Connecting with Key Markets

    FCE Pharma is one of Latin America's leading pharmaceutical industry events, bringing together major companies and professionals from across the pharmaceutical sector. The event covers APIs, FDFs, manufacturing technologies, pharmaceutical equipment, and laboratory services, connecting companies across R&D, manufacturing, and distribution. Each edition attracts more than 550 exhibitors and 28,000 industry professionals from over 50 countries, offering a valuable platform to connect with the Latin American market, explore industry trends, and build new business partnerships.

  Driven by Excellence

     Newland integrates R&D, manufacturing, sales, and technical services. The company focuses on specialty APIs and high-value pharmaceutical intermediates. Relying on the core advantages of chiral drug preparation technology and continuous flow catalytic hydrogenation research platform, the products cover  core medical fields such as anti-infection, diabetes, local anesthesia, cardiovascular and so on. With stable quality and strict quality control, it has been widely recognized in the global market.

   Newland has dedicated R&D teams and modern manufacturing facilities. The company follows international quality standards and maintains a comprehensive quality traceability system throughout the production process. Driven by mature manufacturing technologies, economies of scale, and a resilient supply chain, Newland Pharma's products are exported worldwide, backed by extensive international operational experience and premium partnership networks.

Expanding Our Global Reach

Internationalization remains central to Newland Pharma's strategic vision. The company is continuously optimizing its global marketing and support networks to steadily advance its overseas footprint. Focus on key layouts in Latin America, Southeast Asia, Europe, the Middle East and other regions, where Newland Pharma aligns its product and service architecture with localized market demands. Its participation in FCE Pharma in Brazil marks an important step in its expansion into South America and strengthens its presence in the Latin American market.

Newland works with pharmaceutical companies and research institutions worldwide on technical exchange and joint R&D. It continuously improves its products and manufacturing processes. The company also offers flexible cooperation models across supply chains, distribution channels, and project development. Its goal is to build long-term partnerships and create sustainable value across the global pharmaceutical industry.

Building Lasting Partnerships

At FCE Pharma, Newland Pharma will showcase its core competitive products and innovative technical solutions, demonstrating its comprehensive full-chain capabilities. The company will feature a dedicated one-on-one consultation area at its booth to provide tailored partnership strategies. Global buyers, stakeholders, and industry peers are sincerely invited to visit, explore collaborative synergies, and co-author the future of the pharmaceutical industry.

       Exhibition Information

• Name: FCE Pharma, São Paulo, Brazil

• Venue: São Paulo Expo, São Paulo, Brazil

• Date: June 1–3, 2026

• Booth No.: l53